Literature DB >> 23179793

Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

D K Bartsch1, K Dietzel, M Bargello, E Matthaei, G Kloeppel, I Esposito, J T Heverhagen, T M Gress, E P Slater, P Langer.   

Abstract

Most screening programs for familial pancreatic cancer are currently based on endoscopic ultrasonography and/or magnetic resonance imaging (MRI). Cystic lesions, especially those suspicious for small intraductal pancreatic mucinous neoplasms (IPMNs) of the branch ducts, can be visualized in up to 40 % of individuals at risk, but their pathological importance in the setting of FPC is yet not well established. Individuals at risk from a prospective screening program for familial pancreatic cancer with small "imaging" IPMNs of the branch-duct type (BD-IPMN) who underwent pancreatic resection were analysed regarding clinico-pathological data and the locations of pancreatic lesions. Five of 125 individuals at risk who underwent screening had multiple small (size 2-10 mm) unicystic lesions and/or multicystic single lesions in the pancreatic body and tail suspicious for BD-IPMNs upon MRI imaging and decided to undergo surgical resection after interdisciplinary counselling, although none fulfilled the consensus criteria for IPMN resection. Histological examination revealed BD-IPMNs with low or moderate dysplasia of the gastric type in combination with multifocal PanIN2 and PanIN3 lesions in 4 individuals. The remaining patient had only tiny ductectasias in the pancreatic tail with multifocal PanIN 2 lesions in the entire gland and one PanIN3 lesion in the pancreatic head. Intriguingly, the location of the most dysplastic histological lesions (PanIN3) did not correspond to the preoperatively detected lesions and were not visible in preoperative imaging. In the setting of FPC, the presence of multiple small "imaging" BD-IPMNs may indicate the presence of high-grade PanIN lesions elsewhere in the pancreas.

Entities:  

Mesh:

Year:  2013        PMID: 23179793     DOI: 10.1007/s10689-012-9582-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

1.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

2.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

3.  Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Authors:  Michaela Aichler; Christopher Seiler; Monica Tost; Jens Siveke; Pawel K Mazur; Patricia Da Silva-Buttkus; Detlef K Bartsch; Peter Langer; Sara Chiblak; Anna Dürr; Heinz Höfler; Günter Klöppel; Karin Müller-Decker; Markus Brielmeier; Irene Esposito
Journal:  J Pathol       Date:  2012-01-17       Impact factor: 7.996

4.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

5.  Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Roberto Salvia; Stefano Crippa; Stefano Partelli; Giulia Armatura; Giuseppe Malleo; Marina Paini; Antonio Pea; Claudio Bassi
Journal:  World J Gastrointest Surg       Date:  2010-10-27

6.  PALB2 mutations in European familial pancreatic cancer families.

Authors:  E P Slater; P Langer; E Niemczyk; K Strauch; J Butler; N Habbe; J P Neoptolemos; W Greenhalf; D K Bartsch
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

Review 7.  Pancreatic intraepithelial neoplasia revisited and updated.

Authors:  B Sipos; S Frank; T Gress; S Hahn; G Klöppel
Journal:  Pancreatology       Date:  2008-12-12       Impact factor: 3.996

8.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

9.  Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Authors:  Kathleen M Murphy; Kieran A Brune; Constance Griffin; Jennifer E Sollenberger; Gloria M Petersen; Ravi Bansal; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  Small (Sendai negative) branch-duct IPMNs: not harmless.

Authors:  Stefan Fritz; Miriam Klauss; Frank Bergmann; Thilo Hackert; Werner Hartwig; Oliver Strobel; Bogata D Bundy; Markus W Büchler; Jens Werner
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

View more
  15 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality?

Authors:  Victoria Chernyak; Milana Flusberg; Linda B Haramati; Alla M Rozenblit; Eran Bellin
Journal:  Radiology       Date:  2014-08-12       Impact factor: 11.105

Review 3.  Pancreatic Cancer Screening.

Authors:  Koushik K Das; Dayna Early
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

4.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Authors:  Marcia Irene Canto; Jose Alejandro Almario; Richard D Schulick; Charles J Yeo; Alison Klein; Amanda Blackford; Eun Ji Shin; Abanti Sanyal; Gayane Yenokyan; Anne Marie Lennon; Ihab R Kamel; Elliot K Fishman; Christopher Wolfgang; Matthew Weiss; Ralph H Hruban; Michael Goggins
Journal:  Gastroenterology       Date:  2018-05-24       Impact factor: 22.682

Review 5.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

6.  Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome?

Authors:  Marco Del Chiaro; Raffaella Pozzi Mucelli; John Blomberg; Ralf Segersvärd; Caroline Verbeke
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 7.  Progress report: familial pancreatic cancer.

Authors:  Ioannis Mintziras; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

Review 8.  Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.

Authors:  Stefano Crippa; Alessandra Piccioli; Maria Chiara Salandini; Chiara Cova; Francesca Aleotti; Massimo Falconi
Journal:  Updates Surg       Date:  2016-08-08

9.  Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals.

Authors:  Gabriele Capurso; Marianna Signoretti; Roberto Valente; Urban Arnelo; Matthias Lohr; Jan-Werner Poley; Gianfranco Delle Fave; Marco Del Chiaro
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

10.  Development of a high risk pancreatic screening clinic using 3.0 T MRI.

Authors:  Chad A Barnes; Elizabeth Krzywda; Shannon Lahiff; Dena McDowell; Kathleen K Christians; Paul Knechtges; Parag Tolat; Mark Hohenwalter; Kulwinder Dua; Abdul H Khan; Douglas B Evans; Jennifer Geurts; Susan Tsai
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.